Drugs / GnRH antagonist rescue & cabergoline
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02461875 Background | May 2013 → Nov 2015 | ovarian hyperstimulation syndrome | Aljazeera Hospital | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GnRH antagonist rescue & cabergoline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02461875 ↗ |
| Route | Intramuscular | “HCG (5,000 IU/I.M) is administered” NCT02461875 ↗ |